Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
The lack of a robust anticancer drug screening system to monitor patients during treatment delays realization of personalized treatment. We demonstrate an efficient approach to evaluate drug response using patient-derived circulating tumor cell (CTC) cultures obtained from liquid biopsy. Custom micr...
Main Authors: | Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Lim, C. T., Han, Jongyoon |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2016
|
Online Access: | http://hdl.handle.net/1721.1/106170 https://orcid.org/0000-0001-7215-1439 |
Similar Items
-
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01) -
The importance of circulating tumor products as „liquid biopsies” in colorectal cancer
by: Alina Miscoci, et al.
Published: (2018-04-01) -
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
by: Khoo, Bee Luan, et al.
Published: (2020) -
Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
by: Wei Zhang, et al.
Published: (2017-02-01) -
Circulating tumor DNA detection (liquid biopsy): prospects in oncology
by: N. V. Zhukov, et al.
Published: (2015-01-01)